DiaMedica Therapeutics Inc. (DMAC)
NASDAQ: DMAC · Real-Time Price · USD
3.735
-0.025 (-0.66%)
Apr 1, 2025, 3:59 PM EDT - Market closed
DiaMedica Therapeutics Market Cap
DiaMedica Therapeutics has a market cap or net worth of $161.35 million as of April 1, 2025. Its market cap has increased by 45.62% in one year.
Market Cap
161.35M
Enterprise Value
121.19M
1-Year Change
45.62%
Ranking
Category
Stock Price
$3.74
Market Cap Chart
Since December 7, 2018, DiaMedica Therapeutics's market cap has increased from $36.70M to $161.35M, an increase of 339.65%. That is a compound annual growth rate of 26.41%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 31, 2025 | 162.40M | -30.06% |
Dec 31, 2024 | 232.20M | 115.40% |
Dec 29, 2023 | 107.80M | 157.89% |
Dec 30, 2022 | 41.80M | -57.61% |
Dec 31, 2021 | 98.60M | -48.11% |
Dec 31, 2020 | 190.00M | 226.46% |
Dec 31, 2019 | 58.20M | 68.70% |
Dec 31, 2018 | 34.50M | -5.99% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 726.56B |
UnitedHealth Group | 479.44B |
Johnson & Johnson | 399.67B |
AbbVie | 367.36B |
Novo Nordisk | 305.46B |
AstraZeneca | 229.16B |
Abbott Laboratories | 228.69B |
Merck & Co. | 225.60B |